Medeon Biodesign (ROCO:6499) Total Stockholders Equity : NT$1,925.5 Mil (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Total Stockholders Equity?

Medeon Biodesign's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$1,925.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Medeon Biodesign's Book Value per Share for the quarter that ended in Jun. 2024 was NT$20.90. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Medeon Biodesign's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.10.

Medeon Biodesign Total Stockholders Equity Historical Data

The historical data trend for Medeon Biodesign's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Total Stockholders Equity Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

1,639.24

2,004.23

2,045.04

4,130.33

3,597.44

Medeon Biodesign Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															3,383.19	2,711.82	2,536.18	2,133.55	1,925.51

Medeon Biodesign (ROCO:6499) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Medeon Biodesign's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1925.505	-	0)	/	92.1439
	=	20.90

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Medeon Biodesign's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(52.638	+	140.959)	/	1925.505
	=	0.10

Medeon Biodesign Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign Headlines

No Headlines